International audienceMany methods have been developed for DNA integrity assessment including electrophoresis-based procedures, quantitative PCR, and, more recently, microfluidics-based procedures. DNA integrity evaluation can be employed for characterizing biological samples quality before extensive genomic analysis and also finds applications in reproductive medicine, prenatal diagnostics, or cancer research. In this chapter, we will focus on the assessment of DNA integrity in cancer research. In particular, we will present the application of the determination of DNA integrity for tracking of circulating tumor DNA. Finally, we will conclude by illustrating the potential innovative application of DNA integrity as a biomarker in clinical re...
The analysis of circulating cell free DNA is an important tool for the analysis of tumor resistance,...
This thesis aimed to investigate the clinical applicability of liquid biopsy circulating tumor DNA (...
With the addition of molecular testing to the oncologist’s diagnostic toolbox, patients have benefit...
International audienceMany methods have been developed for DNA integrity assessment including electr...
Tumor-released DNA in blood represents a promising biomarker for cancer detection. It has been postu...
Current approaches for cancer detection and characterization are based on radiological procedures co...
In the era of personalized medicine, tumor sampling is paramount to enable the assessment of actiona...
Yi Chang,1,2,* Bhairavi Tolani,2,* Xiuhong Nie,1 Xiuyi Zhi,3 Mu Hu,3 Biao He2 1Department of Respir...
Cancer individualized therapy often requires for gene mutation analysis of tumor tissue. However, tu...
Next generation sequencing (NGS) has become an informative tool to guide cancer treatment and conduc...
Detection of circulating tumor DNAs (ctDNAs) in cancer patients is an important component of cancer ...
Recently, many genome-wide profiling studies provided insights into the molecular make-up of major c...
Circulating cell-free DNA (cfDNA) and its tumour-derived circulating tumour DNA (ctDNA) fraction are...
Circulating nucleic acids such as DNA and microRNA are released and circulate in the blood of cancer...
Qualitative and quantitative testing of circulating cell free DNA (CCFDNA) can be applied for the ma...
The analysis of circulating cell free DNA is an important tool for the analysis of tumor resistance,...
This thesis aimed to investigate the clinical applicability of liquid biopsy circulating tumor DNA (...
With the addition of molecular testing to the oncologist’s diagnostic toolbox, patients have benefit...
International audienceMany methods have been developed for DNA integrity assessment including electr...
Tumor-released DNA in blood represents a promising biomarker for cancer detection. It has been postu...
Current approaches for cancer detection and characterization are based on radiological procedures co...
In the era of personalized medicine, tumor sampling is paramount to enable the assessment of actiona...
Yi Chang,1,2,* Bhairavi Tolani,2,* Xiuhong Nie,1 Xiuyi Zhi,3 Mu Hu,3 Biao He2 1Department of Respir...
Cancer individualized therapy often requires for gene mutation analysis of tumor tissue. However, tu...
Next generation sequencing (NGS) has become an informative tool to guide cancer treatment and conduc...
Detection of circulating tumor DNAs (ctDNAs) in cancer patients is an important component of cancer ...
Recently, many genome-wide profiling studies provided insights into the molecular make-up of major c...
Circulating cell-free DNA (cfDNA) and its tumour-derived circulating tumour DNA (ctDNA) fraction are...
Circulating nucleic acids such as DNA and microRNA are released and circulate in the blood of cancer...
Qualitative and quantitative testing of circulating cell free DNA (CCFDNA) can be applied for the ma...
The analysis of circulating cell free DNA is an important tool for the analysis of tumor resistance,...
This thesis aimed to investigate the clinical applicability of liquid biopsy circulating tumor DNA (...
With the addition of molecular testing to the oncologist’s diagnostic toolbox, patients have benefit...